For example, AAH offers a slightly better discount on The Roche lines than Alliance, so front-line Phoenix customers who bought their Roche stock from Alliance could switch to AAH. The result could be, as an Alliance, to improve some of its rebates and perhaps even drop its low spending surcharge in order to maintain the dominant position it risks losing at the price of the AAH. Currently, AAH dominates Alliance in the hospital sector, but due to the recent explosion of Solus Arrangements, Alliance are able to offer a wider range of products for the community. Honestly, I don`t think a solus deal is good news, but while this news could be a short-term hurdle for AAH, it could offer some unexpected benefits later. I wouldn`t want Alliance to be too big for his boots… Welcome to the new Alliance Healthcare directory for agency, solus and doubles arrangements. We have changed the way we display these procurement agreements to make it easier for our customers to access information. In any case, now that Alliance has lost the ability to deliver the MSD range, which boils down to many common products, Alliance is no longer able to be the only wholesaler to use, whether it likes it or not – AAH and Alliance are on an equal footing. AAH secured various smaller solus agreements (z.B. Ferring pharma) earlier this year, but MSD is their first solus contract to supply the community pharmacy with a major product manufacturer. The AAH has had numerous Solus agreements on hospital contracts for some time, but so far none of its Solus contracts will have as much effect. Pharmacies that are presented with a prescription for EpiPen 0.3mg or EpiPen Jr 0.15mg of adrenaline auto-injectors can order for up to two devices per prescription.
Please send anonymized prescriptions to Alliance Healthcare`s prescription validation service, by email to firstname.lastname@example.org (or by fax 0330 332 8126). Please include your Alliance Healthcare account number when ordering. Budenofalk, Budenofalk aggregates and Salofalk suppositeurs are only available through our distribution partner Solus AAH. For these products, please call the aah service on 0844 561 8899. These Solus/MDM agreements should have been subject to much more scrutiny from the outset by the competent authorities. Now, years later, it`s actually too late to do much to fix it. Such agreements are totally anti-competitive, they have destroyed some of the small mid-line/regional distributors (which offered both choice and competition for large ones), branded drug prices have increased due to a lack of competition and predictable reductions that have followed. In some cases, independent pharmacies have also lost the ability to get faster deliveries and improve morning downtime through the use of the nearest supplier/deposit. The worst thing, in my opinion, is that these businesses always hit independent pharmacies the hardest because they are not vertically integrated with one of the major wholesalers or they are in possession. As such, they have lost almost all the powers to negotiate discounts on branded drugs.
However, multiples may give as little discount to their own pharmacies as Indians (and seem fair at a glance), but this doesn`t matter to them, because profit from selling the brand remains rather comfortably hidden on the wholesaler`s accounts. I think it will be an unfortunate and restrictive future for pharmacists in the community, when almost every pharmacy in the country ends up being part of Walgreens-Boots or another international giant, because they are the only ones capable (in the end) of making money! We still have a lot of profitable independents at the moment, but each of these new agreements is bad news for each of them, and such agreements are coming at a worrying rate! There certainly won`t be many opportunities for community pharmacists to have a lot of professional independence in the future, unless it becomes viable for more pharmacists to own their own.